Sexually transmitted infections clinical trials group.
Ended Awarded Last action
- Contract number
- 75N93018F00016
- Awardee
-
University Of Alabama At Birmingham UEI YND4PLMC9AN7
- Awarding agency
-
National Institute of Allergy and Infectious Diseases
National Institutes of Health, Department of Health and Human Services
- Obligated
- $1,435,603
Award facts
- Contract value 100% obligated
- $1,435,602.58 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 541711 Research and Development in Biotechnology
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 1 offer Multiple Award, Fair Opportunity
- Pricing
- Cost No Fee
- Place of performance
- Birmingham, AL 35294, USA
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Funding Only Action | -$842,076 | |
| Supplemental Agreement for work within scope | $0 | |
| Supplemental Agreement for work within scope | $0 | |
| Supplemental Agreement for work within scope | $0 | |
| Original award | $2,277,679 |
About this award
This federal contract award was issued by the Department of Health and Human Services' National Institutes of Health, National Institute of Allergy and Infectious Diseases to the University of Alabama at Birmingham (UAB) on September 19, 2018. The $1,435,602.58 delivery order contract supports the Sexually Transmitted Infections Clinical Trials Group and does not have a set-aside designation.
Under this contract, UAB is serving as the prime contractor to develop a protocol and complete a Phase 2 clinical trial to test the safety and limited efficacy of a therapeutic for the treatment of bacterial vaginosis (BV). UAB has engaged two subcontractors - the University of California, San Diego and the University of Pittsburgh - to support specific aspects of the clinical trial protocol development and execution. Both universities have extensive experience supporting federal research contracts and grants across various biomedical, public health, and other scientific domains.
Quick answers
Who was awarded contract 75N93018F00016?
75N93018F00016 was awarded to University Of Alabama At Birmingham by National Institute of Allergy and Infectious Diseases (National Institutes of Health) on September 19, 2018.
How much is contract 75N93018F00016 worth?
The government has obligated $1,435,603 on 75N93018F00016.
Is contract 75N93018F00016 an order under another contract?
Yes. 75N93018F00016 is a delivery order under HHSN272201300012I, an indefinite delivery contract.
Was contract 75N93018F00016 competed?
The extent of competition for 75N93018F00016 was full and open competition. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award